Back to
Duquesne Family Office LLC
RYTM
2 quarters
Position history for
Duquesne Family Office LLC's holdings in Rhythm Pharmaceuticals, Inc.
Yes. Duquesne Family Office holds 269,900 shares of RYTM (Rhythm Pharmaceuticals), worth $25.7M, as of its Q3 2026 13F filing. It increased the position by 66,282 shares (+32.6%) from Q2 2026. Duquesne Family Office has held RYTM since Q2 2026, across 2 quarterly 13F filings. RYTM is 0.6% of Duquesne Family Office's reported 13F portfolio.
Current Value
$25.7M
Current Shares
269,900
Total Value Change
+$3.1M
Total Shares Change
+66,282
Quarter-by-Quarter History
Other major holders of RYTM: RA Capital Management, L.P., BlackRock, Inc., Vanguard Group Inc.